Journal of the American Chemical Society · 2015 · 28 citations · 41 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryStructure-activity RelationshipsSynthetic Medicinal ChemistryCatalytic MechanismsHeterocyclic ChemistryMacrocycle SynthesisRetrosynthetic AnalysisTerpenoid BiosynthesisBergman CyclizationCyclotrimerization Of AlkynesEnantioselective Synthesis
Fijiolide A is a secondary metabolite isolated from a marine-derived actinomycete and displays inhibitory activity against TNF-α-induced activation of NFκB, an important transcription factor and a potential target for the treatment of different cancers and inflammation related diseases. Fijiolide A is a glycosylated complex paracyclophane, which is structurally closely related to the Bergman-aromatization product of enediyne C-1027. We report an enantioselective synthesis of fijiolide A demonstrating the power of fully intermolecular ruthenium-catalyzed [2 + 2 + 2]-cyclotrimerizations with three different alkynes to assemble the heavily substituted central arene core. The characteristic strained [2.6]paracyclophane structure is accessed by a templated atropselective macroetherification reaction.
41
N-methoxy-n-methylamides as effective acylating agents
Steven Nahm, Steven M. Weinreb · Tetrahedron Letters · 1981 · 1.8K citations